Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ESMO 2023
Pharma
Pharma heads for cancer first line, causing early-stage rethink
Cancer drugs are getting better thanks to innovation, driven by the data and regulatory forces like Project FrontRunner.
Annalee Armstrong
Nov 17, 2023 3:00am
Merck's Keytruda mostly won out at ESMO, with one notable miss
Oct 24, 2023 9:05am
Moderna, BioNTech's post-COVID futures hit manufacturing reality
Oct 24, 2023 8:31am
ESMO: Should AZ worry about J&J's Tagrisso head-to-head win?
Oct 23, 2023 10:30am
ESMO: Novartis' Pluvicto posts mixed prostate cancer data
Oct 23, 2023 10:30am
Rain in Spain doesn't dampen spirits of 33,000 oncologists
Oct 23, 2023 8:58am
